Effects of estrogen and testosterone on resting energy expenditure in older men.
The mechanisms by which sex hormones cause changes in body composition are unclear. Sex steroid deficiency might directly reduce energy expenditure/fat oxidation and thereby predispose to increased body fat. Alternatively, sex steroid deficiency could result in lean tissue loss and thus reduced energy expenditure. Our objective was to examine the independent and combined effects of acute testosterone and estrogen withdrawal on respiratory exchange ratio (RER) and resting energy expenditure (REE) in men. The objective of the study was to examine the independent and combined effects of acute estrogen and testosterone withdrawal on RER and REE in men. A total of 54 men aged 50-80 years, BMI range of 17-35 kg/m(2) underwent a 3-week eugonadal run-in hormone-treatment period involving suppression of endogenous sex steroids using letrozole and leuprolide acetate (Lupron) while sex steroid concentrations were maintained with transdermal testosterone (T) and estradiol (E). A second Lupron injection was then given and participants were randomized to one of the following four 3-week treatment groups: group A (-T, -E), group B (-T, +E), group C (+T, -E), and group D (+T, +E). REE and RER were measured via indirect calorimetry before and after the 3-week treatment period. Three-week suppression and/or repletion of estrogen or testosterone did not produce changes in RER or REE within or between groups. We conclude that abrupt changes in sex steroids does not change resting substrate oxidation, indicating that changes that can be observed after more prolonged periods of deficiency are most likely due to direct effects of sex steroids on body composition.
Santosa
Sylvia
S
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
Khosla
Sundeep
S
McCready
Louise K
LK
Jensen
Michael D
MD
D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D001481:Basal Metabolism / Q000187:drug effects*; D002153:Calorimetry, Indirect; D002245:Carbon Dioxide / Q000378:metabolism; D004967:Estrogens / Q000172:deficiency / Q000494:pharmacology*; D006801:Humans; D000077289:Letrozole; D016729:Leuprolide / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D013739:Testosterone / Q000172:deficiency / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology
D004967:Estrogens; D009570:Nitriles; D014230:Triazoles; D002245:Carbon Dioxide; D013739:Testosterone; D000077289:Letrozole; D016729:Leuprolide
J Clin Endocrinol Metab. 1996 Jun;81(6):2198-203
8964851
JPEN J Parenter Enteral Nutr. 1991 Mar-Apr;15(2):165-8
2051556
J Appl Physiol (1985). 2005 Nov;99(5):1930-7
15994239
J Clin Endocrinol Metab. 2008 Jan;93(1):139-46
17940111
J Clin Invest. 2003 Apr;111(7):981-8
12671047
Am J Clin Nutr. 2008 Jul;88(1):95-104
18614729
Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E266-71
15727949
J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72
15472177
J Clin Endocrinol Metab. 2004 Feb;89(2):718-26
14764787
Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E531-5
18492764
J Clin Endocrinol Metab. 2005 Jun;90(6):3592-9
15755861
Maturitas. 2003 Sep 25;46(1):59-68
12963170
Growth Horm IGF Res. 2008 Feb;18(1):55-64
17714967
J Clin Endocrinol Metab. 1998 Jun;83(6):1886-92
9626114
J Bone Miner Res. 2008 May;23(5):705-14
18086006